2017 FDA Data Integrity for Computerized Systems Seminar by GlobalCompliancePanel

  • 209.00 Dollar US$
  • Published date: February 16, 2017
    • Mumbai, India

Overview:
The Problem:
We have all heard of Data Integrity but do you really understand what it is? Do you understand how 21 CFR 11 and Annex 11 fit into this picture? Specifically, can you answer questions on the following?
• Evolution of 21 CFR Part 11 and Annex 11 and Why they are Back in the News
• Overview and Key Requirements of Part 11 & Annex 11
• How to use a Risk Based Assessment to reduce work while still achieving Data Integrity and Compliance?
• How FDA & other Regulatory Authorities Inspect Computerized Systems for Data Integrity?
I often refer to 21 CFR 11 and Annex 11 as Good Software Engineering with the Documentation on Steroids! However, unless one knows how to implement Data Integrity, it is often very hard to apply requirements for DATA INTEGRITY to computerized system, and very hard to determine what needs to be done, to meet domestic and / or international regulations or business continuity requirements. In addition, the agencies have stepped up data integrity inspections and the number of citations on the subject is skyrocketing!
This course is appropriate for beginner and experienced person alike. The topics will build on each other and will give you the latest trends in our heavily regulated industry and how to make it easy for yourself while still achieving data integrity.

Location: Mumbai, India Date: April 27th & 28th, 2017 and Time: 9:00 AM to 6:00 PM

Venue: The LaLiT Mumbai
Address: Sahar Airport Road, Andheri East, Mumbai - 400059

Price:

Register now and save ₹ 2000. (Early Bird)

Price: ₹ 14,000 (Seminar for one Delegate)

Until March 25, Early Bird Price: 14,000 From March 26 to April 25, Regular Price: 16,000
Registration Details:
NetZealous - GlobalCompliancePanel
NetZealous Services India Pvt. Ltd.
Gururaya Mansion, 759 to 764, 8th Main road, J.P.Nagar,
Bangalore - 560078 Karnataka, INDIA
Phone: 1800 425 9409
Fax: 080-25149544
smanzoor@netzealous.com
http://www.globalcompliancepanel.in/
Registration Link – https://www.globalcompliancepanel.in/control/FDA-data-integrity-21-CFR-11-Mumbai?channel=mailer&camp=seminar&AdGroup=science-marketplace.org_APR_2017_SEO
Follow us on LinkedIn: https://www.linkedin.com/company/globalcompliancepanelindia

Result 0 votes
John Robinson
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Anti-CD138 CAR-T Preclinical in vivo Assay

    Anti-CD138 CAR-T Preclinical in vivo Assay

    Drug Development (United States ) November 24, 2016 Check with publisher

    Creative Biolabs has partnered with scores of research institutes and hospitals to get access to the resources such as patient primary samples, which are essential for the establishment of PDX models. The traditional xenograft models, in alliance wit...

  • Anti-NKG2D-ligand CAR-T Preclinical in vivo Assay

    Anti-NKG2D-ligand CAR-T Preclinical in vivo Assay

    Drug Development (United States ) November 24, 2016 Check with publisher

    Creative Biolabs intends to break through the limits in line with conventional animal models and to explore more eminent types presenting good adaptability and clinical similarity such as patient cell derived mouse models and humanized-xenograft mode...

  • Anti-MUC1 CAR-T Preclinical in vivo Assay

    Anti-MUC1 CAR-T Preclinical in vivo Assay

    Drug Development (United States ) November 24, 2016 Check with publisher

    At Creative Biolabs, we are dedicated to establish the most reliable tumor models and the most accurate research procedures by keeping up with the science pace towards CAR-T in vivo study in order to promote the transformation of preclinical research...